PRS
MGNX icon

Pinkerton Retirement Specialists’s MacroGenics MGNX Stock Holding History

Pinkerton Retirement Specialists’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-17
Closed – – 349
2016
Q4 		$0 Hold
17
– – ﹤0.01% 637
2016
Q3 		$1K Sell
17
-5
-23% -$149 ﹤0.01% 566
2016
Q2 		$1K Buy
+22
New +$496 ﹤0.01% 573

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Pinkerton Retirement Specialists's MGNX Position: Q1 2017 in Review

Pinkerton Retirement Specialists sold out of MacroGenics (MGNX) in Q1 2017, closing a stake of 17 shares.

Pinkerton Retirement Specialists first reported a position in MGNX in Q2 2016 and held it in 3 quarters. The position peaked at $1K in Q3 2016. 111 funds tracked by Wall St. Rank hold MGNX as of Q1 2017.

  • Pinkerton Retirement Specialists reported no remaining MacroGenics position as of Q1 2017 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 17 MacroGenics shares in Q1 2017.
  • Pinkerton Retirement Specialists first reported a position in MacroGenics in Q2 2016 and held it in 3 quarters.
  • Pinkerton Retirement Specialists's MacroGenics position peaked at $1K in Q3 2016.
  • 111 funds tracked by Wall St. Rank held MacroGenics as of Q1 2017.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2017, filed 15 May 2017.